Heather A Pines1, Thomas L Patterson2, Gudelia Rangel3, Gustavo Martinez4, Angela R Bazzi5, Monica D Ulibarri2, Jennifer L Syvertsen6, Natasha K Martin7, Steffanie A Strathdee1. 1. Division of Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, USA. 2. Department of Psychiatry, University of California, San Diego, La Jolla, USA. 3. Department of Population Studies, El Colegio de La Frontera Norte, Tijuana, Baja California, México. 4. Federación Mexicana de Asociaciones Privadas (FEMAP), Ciudad Juárez, Chihuahua, México. 5. Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, USA. 6. Department of Anthropology, The Ohio State University, Columbus, USA. 7. School of Social and Community Medicine, University of Bristol, Bristol, UK Social and Mathematical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
Abstract
OBJECTIVES: Disclosure of sexually transmitted infections (STI)/HIV diagnoses to sexual partners is not mandated by public health guidelines in Mexico. To assess the feasibility of couples-based STI/HIV testing with facilitated disclosure as a risk-reduction strategy within female sex workers' (FSW) primary partnerships, we examined STI/HIV test result disclosure patterns between FSWs and their primary, non-commercial male partners in two Mexico-US border cities. METHODS: From 2010 to 2013, 335 participants (181 FSWs and 154 primary male partners) were followed for 24 months. At semiannual visits, participants were tested for STIs/HIV and reported on their disclosure of test results from the previous visit. Multilevel logistic regression was used to identify individual-level and partnership-level predictors of cumulative (1) non-disclosure of ≥1 STI test result and (2) non-disclosure of ≥1 HIV test result within couples during follow-up. RESULTS: Eighty-seven percent of participants reported disclosing all STI/HIV test results to their primary partners. Non-disclosure of ≥1 STI test result was more common among participants who reported an STI diagnosis as part of the study (adjusted OR=3.05, 95% CI 1.13 to 8.25), while non-disclosure of ≥1 HIV test result was more common among participants in longer-duration partnerships (AOR=1.15 per year, 95% CI 1.03 to 1.28). Drug use before/during sex within partnerships was associated with non-disclosure of both STI (AOR=5.06, 95% CI 1.64 to 15.62) and HIV (AOR=4.51, 95% CI: 1.32 to 15.39) test results. CONCLUSIONS: STI/HIV test result disclosure was highly prevalent within FSWs' primary partnerships, suggesting couples-based STI/HIV testing with facilitated disclosure may be feasible for these and potentially other high-risk, socially marginalised couples. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVES: Disclosure of sexually transmitted infections (STI)/HIV diagnoses to sexual partners is not mandated by public health guidelines in Mexico. To assess the feasibility of couples-based STI/HIV testing with facilitated disclosure as a risk-reduction strategy within female sex workers' (FSW) primary partnerships, we examined STI/HIV test result disclosure patterns between FSWs and their primary, non-commercial male partners in two Mexico-US border cities. METHODS: From 2010 to 2013, 335 participants (181 FSWs and 154 primary male partners) were followed for 24 months. At semiannual visits, participants were tested for STIs/HIV and reported on their disclosure of test results from the previous visit. Multilevel logistic regression was used to identify individual-level and partnership-level predictors of cumulative (1) non-disclosure of ≥1 STI test result and (2) non-disclosure of ≥1 HIV test result within couples during follow-up. RESULTS: Eighty-seven percent of participants reported disclosing all STI/HIV test results to their primary partners. Non-disclosure of ≥1 STI test result was more common among participants who reported an STI diagnosis as part of the study (adjusted OR=3.05, 95% CI 1.13 to 8.25), while non-disclosure of ≥1 HIV test result was more common among participants in longer-duration partnerships (AOR=1.15 per year, 95% CI 1.03 to 1.28). Drug use before/during sex within partnerships was associated with non-disclosure of both STI (AOR=5.06, 95% CI 1.64 to 15.62) and HIV (AOR=4.51, 95% CI: 1.32 to 15.39) test results. CONCLUSIONS: STI/HIV test result disclosure was highly prevalent within FSWs' primary partnerships, suggesting couples-based STI/HIV testing with facilitated disclosure may be feasible for these and potentially other high-risk, socially marginalised couples. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Stefan Baral; Chris Beyrer; Kathryn Muessig; Tonia Poteat; Andrea L Wirtz; Michele R Decker; Susan G Sherman; Deanna Kerrigan Journal: Lancet Infect Dis Date: 2012-03-15 Impact factor: 25.071
Authors: Angela M Robertson; Jennifer L Syvertsen; Monica D Ulibarri; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee Journal: J Urban Health Date: 2014-08 Impact factor: 3.671
Authors: Jennifer L Syvertsen; Angela M Robertson; Lawrence A Palinkas; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee Journal: Cult Health Sex Date: 2013-03-11
Authors: Jennifer L Syvertsen; Angela M Robertson; María Luisa Rolón; Lawrence A Palinkas; Gustavo Martinez; M Gudelia Rangel; Steffanie A Strathdee Journal: Soc Sci Med Date: 2013-03-18 Impact factor: 4.634
Authors: Angela M Robertson; Jennifer L Syvertsen; Lawrence A Palinkas; Alicia Vera; Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee Journal: Sex Transm Dis Date: 2013-10 Impact factor: 2.830
Authors: Andrew Medina-Marino; Katherine Glockner; Emily Grew; Lindsey De Vos; Dawie Olivier; Jeffrey Klausner; Joseph Daniels Journal: BMC Public Health Date: 2020-04-28 Impact factor: 3.295
Authors: Jesse L Clark; Amaya G Perez-Brumer; Eddy R Segura; Hector J Salvatierra; Jorge Sanchez; Javier R Lama Journal: PLoS One Date: 2016-09-29 Impact factor: 3.240